Cookie and data protection information

This website uses cookies & third-party applications to enable certain functions and to improve the offer.

Schützt vor Cross-Site-Request-Forgery Angriffen.

Retention period: Dieses Cookie bleibt nur für die aktuelle Browsersitzung bestehen.

Speichert die aktuelle PHP-Session.

Retention period: Dieses Cookie bleibt nur für die aktuelle Browsersitzung bestehen.

Third party applications for analysis purposes for our website

Provider: Google Ireland Ltd., Gordon House, Barrow Street, Dublin 4, Ireland
Retention period: More about sessions duration https://policies.google.com/privacy.
Data Protection
MiGenTra
Skip navigation
  • Company
  • Capabilities
  • Facilities
  • Careers
  • News
  • Contact
 
  • Company
  • Capabilities
    • Biosimilars
    • Cell and Gene Therapies (CGT)
    • Vaccines
    • Contact
  • Facilities
    • ProBioGen
    • Minapharm Pharmaceuticals
    • Get in Touch
  • Careers
  • News
  • Contact
    • General Contact
    • Legal Notice
    • Disclaimer
    • Data Protection

Press Releases

May 18, 2022

MiGenTra Marks One-Year Anniversary by Attending Africa Health ExCon 2022

read more

  • download PDF

Mar 07, 2022

Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe

read more

  • download PDF

Mar 02, 2022

Product Development Company MiGenTra Announces Formation of International Advisory Board

 

 

read more

  • download PDF

May 27, 2021

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH – A Healthcare Transforming Medicines Company

read more

  • download PDF

Press Contact

Sarah Wandrey, Corporate Communications

Sarah Wandrey
Corporate Communications
Phone: +49 (0) 30 3229 35 144
Email: press@probiogen.de

MiGenTra GmbH

  • Headquarters
  • Herbert-Bayer-Straße 4
  • 13086 Berlin, Germany
  • Phone: +49 (0) 30 5771 4380
  • Email: info@migentra.com
Follow us

Copyright © 2021 MiGenTra GmbH
Legal Notice | Disclaimer | Data Protection